TIS tissue therapies limited

Well 30 days is neally up,looks like option 2BSI has further...

  1. 533 Posts.
    lightbulb Created with Sketch. 49
    Well 30 days is neally up,looks like option 2



    BSI has further advised the Company that the review by MHRA will take up to 30 calendar days, plus
    any additional days necessary for questions to the Company and for Tissue Therapies’ staff to reply to
    MHRA. There are no additional charges for the MHRA review.



    It is possible that the MHRA review may result in a further referral to the European Medicines Agency
    (EMA) for a review of the VitroGro® ECM manufacturing process. EMA is the European Union health
    regulatory agency.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.